3XV

Xvivo Perfusion AB (3XV)

Market Closed
5 Dec, 20:00
XFRA XFRA
16. 04
+0.46
+2.95%
- Market Cap
384.18 P/E Ratio
0% Div Yield
133 Volume
1.4 Eps
15.58
Previous Close
Day Range
16.04 16.04
Year Range
14.45 44.4
Want to track 3XV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 49 days
3XV
3XV Xvivo Perfusion AB
27 Jan 2026 (In 1 month)
-
Cons. EPS
-
EPS
3XV
3XV Xvivo Perfusion AB
26 Jan 2026 (In 1 month)
-
Cons. EPS
-
EPS
3XV
3XV Xvivo Perfusion AB
23 Oct 2025
2.06
Cons. EPS
-
EPS
3XV
3XV Xvivo Perfusion AB
11 Jul 2025
0.63
Cons. EPS
-
EPS
3XV
3XV Xvivo Perfusion AB
22 Apr 2025
-
Cons. EPS
-
EPS
3XV
3XV Xvivo Perfusion AB
28 Jan 2025
-
Cons. EPS
-
EPS
3XV
3XV Xvivo Perfusion AB
24 Oct 2024
-
Cons. EPS
-
EPS
3XV
3XV Xvivo Perfusion AB
12 Jul 2024
-
Cons. EPS
-
EPS
3XV
3XV Xvivo Perfusion AB
10 May 2024
-
Cons. EPS
-
EPS
3XV
3XV Xvivo Perfusion AB
24 Apr 2024
-
Cons. EPS
-
EPS

3XV Earnings Reports FAQ

What is the earnings per share (EPS) for 3XV?

The current EPS is 1.4.

What is the company's earnings growth rate?

Xvivo Perfusion AB has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-01-26, based on the 3XV's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Xvivo Perfusion AB are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 3XV at this time, as Xvivo Perfusion AB has no recent EPS data to calculate it.